Nalaganje...
Silibinin preferentially radiosensitizes prostate cancer by inhibiting DNA repair signaling
Radiotherapy, a frequent mode of cancer treatment, is often restricted by dose-related toxicity and development of therapeutic resistance. To develop a novel and selective radiosensitizer, we studied the radiosensitizing effects and associated mechanisms of silibinin in prostate cancer (PCa). The ra...
Shranjeno v:
| izdano v: | Mol Cancer Ther |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2015
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4674330/ https://ncbi.nlm.nih.gov/pubmed/26516160 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-15-0348 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|